• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


AC8 AusCann Neuvis Capsule Successfully Completes Phase I StudyPRICE SENSITIVE14/09/20 download Created with Sketch. 141.62KB
AC8 AusCann Supports Interim TGA Decision for OTC CBD10/09/20 download Created with Sketch. 88.74KB
AC8 Appendix 4E and Preliminary Financial ReportPRICE SENSITIVE27/08/20 download Created with Sketch. 264.69KB
AC8 AusCann Appoints Nick Woolf as Chief Executive OfficerPRICE SENSITIVE05/08/20 download Created with Sketch. 159.25KB
AC8 June 2020 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE29/07/20 download Created with Sketch. 1.05MB
AC8 Small Shareholding Sale Facility17/07/20 download Created with Sketch. 674.58KB
AC8 S&P DJI Announces June 2020 Quarterly RebalancePRICE SENSITIVE12/06/20 download Created with Sketch. 223.16KB
AC8 Appendix 3G10/06/20 download Created with Sketch. 238.22KB
AC8 AusCann Announces Leadership Change07/05/20 download Created with Sketch. 103.08KB
AC8 AusCann Commences Clinical EvaluationPRICE SENSITIVE28/04/20 download Created with Sketch. 107.23KB
AC8 March 2020 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE20/04/20 download Created with Sketch. 1005.12KB
AC8 Change of Registered Office01/04/20 download Created with Sketch. 83.31KB
AC8 AusCann to Commence Clinical Trial and Product DistributionPRICE SENSITIVE31/03/20 download Created with Sketch. 94.82KB
AC8 AusCann Receives R&D Tax Incentive Refund of $1.2m23/03/20 download Created with Sketch. 85.87KB
AC8 AusCann appoints Chief Medical Advisor12/03/20 download Created with Sketch. 89.77KB
AC8 Change of Director's Interest Notice - K. Bates10/03/20 download Created with Sketch. 170.6KB
AC8 Change of Director's Interest Notice - K. Bates06/03/20 download Created with Sketch. 177.21KB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2019PRICE SENSITIVE28/02/20 download Created with Sketch. 919.65KB
AC8 CH2 appointed to distribute AusCann's products in AustraliaPRICE SENSITIVE24/02/20 download Created with Sketch. 143.82KB
AC8 AusCann Releases Low-dose Form CapsulePRICE SENSITIVE18/02/20 download Created with Sketch. 106.64KB
AC8 December 2019 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE30/01/20 download Created with Sketch. 1MB
AC8 Final Director's Interest Notice - C. Edwardes20/01/20 download Created with Sketch. 325.7KB
AC8 Appendix 3B23/12/19 download Created with Sketch. 177.27KB
AC8 Initial Director's Interest Notice x 220/12/19 download Created with Sketch. 122.04KB
AC8 New Chairman and Independent Director Appointments20/12/19 download Created with Sketch. 152.78KB
AC8 AusCann Releases Hard-shell Capsules to Clinical EvaluationPRICE SENSITIVE18/12/19 download Created with Sketch. 164.09KB
AC8 AC8 Reinstated on Pershing Securities Trading Cannabis List13/12/19 download Created with Sketch. 97.22KB
AC8 Initial Director's Interest Notice - C. Mews02/12/19 download Created with Sketch. 138.33KB
AC8 Results of Annual General Meeting29/11/19 download Created with Sketch. 200.58KB
AC8 2019 Annual General Meeting - CEO Presentation29/11/19 download Created with Sketch. 7.11MB
AC8 Pharmaceutical Packaging Agreement with Aspen PharmacarePRICE SENSITIVE25/11/19 download Created with Sketch. 117.59KB
AC8 Final Director's Interest Notice - P. MacLeman04/11/19 download Created with Sketch. 172.42KB
AC8 AusCann Effects Board Changes04/11/19 download Created with Sketch. 120.05KB
AC8 Change in substantial holding01/11/19 download Created with Sketch. 206.76KB
AC8 Annual Report29/10/19 download Created with Sketch. 3.71MB
AC8 Notice of Annual General Meeting/Proxy Form28/10/19 download Created with Sketch. 514.52KB
AC8 Final Director's Interest Notice - M. Washer28/10/19 download Created with Sketch. 74.76KB
AC8 AusCann Board Renewal28/10/19 download Created with Sketch. 116.54KB
AC8 September 2019 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE25/10/19 download Created with Sketch. 1.06MB
AC8 Change in substantial holding18/10/19 download Created with Sketch. 213.97KB
AC8 Ceasing to be a substantial holder17/10/19 download Created with Sketch. 225.45KB
AC8 AusCann Substantial Shareholder Change14/10/19 download Created with Sketch. 120.75KB
AC8 Becoming a substantial holder11/10/19 download Created with Sketch. 193.13KB
AC8 AusCann Investor Webinar Recording27/09/19 download Created with Sketch. 94.35KB
AC8 Ceasing to be a substantial holder26/09/19 download Created with Sketch. 493.84KB
AC8 Appendix 4G and Corporate Governance Statement25/09/19 download Created with Sketch. 389.71KB
AC8 30 June 2019 Annual Financial Report25/09/19 download Created with Sketch. 918.12KB
AC8 AusCann Investor Webinar12/09/19 download Created with Sketch. 117.6KB
AC8 Investor Presentation - September 201911/09/19 download Created with Sketch. 3.79MB
AC8 Initial Director's Interest Notice05/09/19 download Created with Sketch. 70KB
AC8 Final Director's Interest Notice x 205/09/19 download Created with Sketch. 92.59KB
AC8 Pharmaceutical Executive Appointed to AusCann Board05/09/19 download Created with Sketch. 107.1KB
AC8 Appendix 4E and Preliminary Financial ReportPRICE SENSITIVE29/08/19 download Created with Sketch. 223.34KB
AC8 June 2019 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/07/19 download Created with Sketch. 356.45KB
AC8 Appendix 3B & s708A(5)(e) Notice24/07/19 download Created with Sketch. 288.37KB
AC8 New Supply Agreement with TasAlkPRICE SENSITIVE01/07/19 download Created with Sketch. 114.03KB
AC8 Change in substantial holding12/06/19 download Created with Sketch. 121.3KB
AC8 Appendix 3B & s708A(5)(e) Notice11/06/19 download Created with Sketch. 312.09KB
AC8 New CEO Commences at AusCann22/05/19 download Created with Sketch. 108.64KB
AC8 March 2019 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE30/04/19 download Created with Sketch. 308.62KB
AC8 Appendix 3B & s708A(5)(e) Notice17/04/19 download Created with Sketch. 308.78KB
AC8 Appendix 3B & s708A(5)(e) Notice04/04/19 download Created with Sketch. 282.53KB
AC8 Change of Director's Interest Notice - P. MacLeman27/03/19 download Created with Sketch. 104.43KB
AC8 Change of Director's Interest Notice - M. Washer12/03/19 download Created with Sketch. 107.66KB
AC8 S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19 download Created with Sketch. 175.31KB
AC8 Investor PresentationPRICE SENSITIVE07/03/19 download Created with Sketch. 6.57MB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2018PRICE SENSITIVE28/02/19 download Created with Sketch. 523.84KB
AC8 AC8 Appoints Experienced Global Pharma Executive as New CEOPRICE SENSITIVE25/02/19 download Created with Sketch. 124.01KB
AC8 AusCann Signs Cannabis Resin Supply Agreement with MediPharmPRICE SENSITIVE21/02/19 download Created with Sketch. 113.72KB
AC8 Appendix 3B - Release from Escrow07/02/19 download Created with Sketch. 181.67KB
AC8 Appointment of Joint Company Secretary01/02/19 download Created with Sketch. 96.86KB
AC8 December 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/01/19 download Created with Sketch. 1.09MB
AC8 AusCann Establishes Research and Development FacilityPRICE SENSITIVE25/01/19 download Created with Sketch. 111.2KB
AC8 AusCann JV commences first cultivation activity with KhironPRICE SENSITIVE22/01/19 download Created with Sketch. 101.44KB
AC8 Notification of Release of Securities from Escrow17/01/19 download Created with Sketch. 101.96KB
AC8 Final Director's Interest Notice02/01/19 download Created with Sketch. 81.96KB
AC8 AusCann Leadership Transition UpdatePRICE SENSITIVE17/12/18 download Created with Sketch. 103.27KB
AC8 Results of Annual General Meeting27/11/18 download Created with Sketch. 147.53KB
AC8 Annual General Meeting Presentation27/11/18 download Created with Sketch. 3.37MB
AC8 AC8 Moves First Products to Commercial Manufacturing SitePRICE SENSITIVE13/11/18 download Created with Sketch. 119.51KB
AC8 September 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE30/10/18 download Created with Sketch. 1.15MB
AC8 Annual Report26/10/18 download Created with Sketch. 10.88MB
AC8 Notice of Annual General Meeting/Proxy Form26/10/18 download Created with Sketch. 576.35KB
AC8 AusCann Releases Cannabinoid Medical Education Resources02/10/18 download Created with Sketch. 327.28KB
AC8 AusCann Joint Venture Signs MoU with Khiron Life SciencesPRICE SENSITIVE01/10/18 download Created with Sketch. 114.25KB
AC8 Pharmaceutical Executive Joins AusCann Board & Appendix 3X27/09/18 download Created with Sketch. 164.24KB
AC8 AusCann Announces Leadership TransitionPRICE SENSITIVE27/09/18 download Created with Sketch. 109.38KB
AC8 Appendix 4G and 2018 Corporate Governance Statement24/09/18 download Created with Sketch. 391.93KB
AC8 30 June 2018 Annual Financial Report24/09/18 download Created with Sketch. 1.09MB
AC8 AusCann Commences Trading on US OTCQX Market12/09/18 download Created with Sketch. 106.93KB
AC8 Progress Towards Production of Cannabinoid Medicines in FY1831/08/18 download Created with Sketch. 141.11KB
AC8 Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/18 download Created with Sketch. 398.66KB
AC8 Successful Pilot Study of Final Dose Cannabinoid CapsulesPRICE SENSITIVE16/08/18 download Created with Sketch. 112.35KB
AC8 Change of Director's Interest Notice - B. McHarrie13/08/18 download Created with Sketch. 108.85KB
AC8 Appendix 3B09/08/18 download Created with Sketch. 165.85KB
AC8 AusCann Share Purchase Plan Raises $1.9mPRICE SENSITIVE09/08/18 download Created with Sketch. 109.97KB
AC8 June 2018 Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/07/18 download Created with Sketch. 471.63KB
AC8 Share Purchase Plan (SPP) Offer Document19/07/18 download Created with Sketch. 335.98KB
AC8 Response to ASX Aware QueryPRICE SENSITIVE19/07/18 download Created with Sketch. 742.64KB
AC8 AusCann Share Purchase PlanPRICE SENSITIVE16/07/18 download Created with Sketch. 140.61KB
AC8 AusCann Neuvis Capsule Successfully Completes Phase I Study
14/09/20PRICE SENSITIVE download Created with Sketch. 141.62KB
AC8 AusCann Supports Interim TGA Decision for OTC CBD
10/09/20 download Created with Sketch. 88.74KB
AC8 Appendix 4E and Preliminary Financial Report
27/08/20PRICE SENSITIVE download Created with Sketch. 264.69KB
AC8 AusCann Appoints Nick Woolf as Chief Executive Officer
05/08/20PRICE SENSITIVE download Created with Sketch. 159.25KB
AC8 June 2020 Quarterly Activities and Cashflow Reports
29/07/20PRICE SENSITIVE download Created with Sketch. 1.05MB
AC8 Small Shareholding Sale Facility
17/07/20 download Created with Sketch. 674.58KB
AC8 S&P DJI Announces June 2020 Quarterly Rebalance
12/06/20PRICE SENSITIVE download Created with Sketch. 223.16KB
AC8 Appendix 3G
10/06/20 download Created with Sketch. 238.22KB
AC8 AusCann Announces Leadership Change
07/05/20 download Created with Sketch. 103.08KB
AC8 AusCann Commences Clinical Evaluation
28/04/20PRICE SENSITIVE download Created with Sketch. 107.23KB
AC8 March 2020 Quarterly Activities and Cashflow Reports
20/04/20PRICE SENSITIVE download Created with Sketch. 1005.12KB
AC8 Change of Registered Office
01/04/20 download Created with Sketch. 83.31KB
AC8 AusCann to Commence Clinical Trial and Product Distribution
31/03/20PRICE SENSITIVE download Created with Sketch. 94.82KB
AC8 AusCann Receives R&D Tax Incentive Refund of $1.2m
23/03/20 download Created with Sketch. 85.87KB
AC8 AusCann appoints Chief Medical Advisor
12/03/20 download Created with Sketch. 89.77KB
AC8 Change of Director's Interest Notice - K. Bates
10/03/20 download Created with Sketch. 170.6KB
AC8 Change of Director's Interest Notice - K. Bates
06/03/20 download Created with Sketch. 177.21KB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2019
28/02/20PRICE SENSITIVE download Created with Sketch. 919.65KB
AC8 CH2 appointed to distribute AusCann's products in Australia
24/02/20PRICE SENSITIVE download Created with Sketch. 143.82KB
AC8 AusCann Releases Low-dose Form Capsule
18/02/20PRICE SENSITIVE download Created with Sketch. 106.64KB
AC8 December 2019 Quarterly Activities and Cashflow Reports
30/01/20PRICE SENSITIVE download Created with Sketch. 1MB
AC8 Final Director's Interest Notice - C. Edwardes
20/01/20 download Created with Sketch. 325.7KB
AC8 Appendix 3B
23/12/19 download Created with Sketch. 177.27KB
AC8 Initial Director's Interest Notice x 2
20/12/19 download Created with Sketch. 122.04KB
AC8 New Chairman and Independent Director Appointments
20/12/19 download Created with Sketch. 152.78KB
AC8 AusCann Releases Hard-shell Capsules to Clinical Evaluation
18/12/19PRICE SENSITIVE download Created with Sketch. 164.09KB
AC8 AC8 Reinstated on Pershing Securities Trading Cannabis List
13/12/19 download Created with Sketch. 97.22KB
AC8 Initial Director's Interest Notice - C. Mews
02/12/19 download Created with Sketch. 138.33KB
AC8 Results of Annual General Meeting
29/11/19 download Created with Sketch. 200.58KB
AC8 2019 Annual General Meeting - CEO Presentation
29/11/19 download Created with Sketch. 7.11MB
AC8 Pharmaceutical Packaging Agreement with Aspen Pharmacare
25/11/19PRICE SENSITIVE download Created with Sketch. 117.59KB
AC8 Final Director's Interest Notice - P. MacLeman
04/11/19 download Created with Sketch. 172.42KB
AC8 AusCann Effects Board Changes
04/11/19 download Created with Sketch. 120.05KB
AC8 Change in substantial holding
01/11/19 download Created with Sketch. 206.76KB
AC8 Annual Report
29/10/19 download Created with Sketch. 3.71MB
AC8 Notice of Annual General Meeting/Proxy Form
28/10/19 download Created with Sketch. 514.52KB
AC8 Final Director's Interest Notice - M. Washer
28/10/19 download Created with Sketch. 74.76KB
AC8 AusCann Board Renewal
28/10/19 download Created with Sketch. 116.54KB
AC8 September 2019 Quarterly Activities and Cashflow Reports
25/10/19PRICE SENSITIVE download Created with Sketch. 1.06MB
AC8 Change in substantial holding
18/10/19 download Created with Sketch. 213.97KB
AC8 Ceasing to be a substantial holder
17/10/19 download Created with Sketch. 225.45KB
AC8 AusCann Substantial Shareholder Change
14/10/19 download Created with Sketch. 120.75KB
AC8 Becoming a substantial holder
11/10/19 download Created with Sketch. 193.13KB
AC8 AusCann Investor Webinar Recording
27/09/19 download Created with Sketch. 94.35KB
AC8 Ceasing to be a substantial holder
26/09/19 download Created with Sketch. 493.84KB
AC8 Appendix 4G and Corporate Governance Statement
25/09/19 download Created with Sketch. 389.71KB
AC8 30 June 2019 Annual Financial Report
25/09/19 download Created with Sketch. 918.12KB
AC8 AusCann Investor Webinar
12/09/19 download Created with Sketch. 117.6KB
AC8 Investor Presentation - September 2019
11/09/19 download Created with Sketch. 3.79MB
AC8 Initial Director's Interest Notice
05/09/19 download Created with Sketch. 70KB
AC8 Final Director's Interest Notice x 2
05/09/19 download Created with Sketch. 92.59KB
AC8 Pharmaceutical Executive Appointed to AusCann Board
05/09/19 download Created with Sketch. 107.1KB
AC8 Appendix 4E and Preliminary Financial Report
29/08/19PRICE SENSITIVE download Created with Sketch. 223.34KB
AC8 June 2019 Quarterly Activities and Cashflow Reports
31/07/19PRICE SENSITIVE download Created with Sketch. 356.45KB
AC8 Appendix 3B & s708A(5)(e) Notice
24/07/19 download Created with Sketch. 288.37KB
AC8 New Supply Agreement with TasAlk
01/07/19PRICE SENSITIVE download Created with Sketch. 114.03KB
AC8 Change in substantial holding
12/06/19 download Created with Sketch. 121.3KB
AC8 Appendix 3B & s708A(5)(e) Notice
11/06/19 download Created with Sketch. 312.09KB
AC8 New CEO Commences at AusCann
22/05/19 download Created with Sketch. 108.64KB
AC8 March 2019 Quarterly Activities and Cashflow Reports
30/04/19PRICE SENSITIVE download Created with Sketch. 308.62KB
AC8 Appendix 3B & s708A(5)(e) Notice
17/04/19 download Created with Sketch. 308.78KB
AC8 Appendix 3B & s708A(5)(e) Notice
04/04/19 download Created with Sketch. 282.53KB
AC8 Change of Director's Interest Notice - P. MacLeman
27/03/19 download Created with Sketch. 104.43KB
AC8 Change of Director's Interest Notice - M. Washer
12/03/19 download Created with Sketch. 107.66KB
AC8 S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE download Created with Sketch. 175.31KB
AC8 Investor Presentation
07/03/19PRICE SENSITIVE download Created with Sketch. 6.57MB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2018
28/02/19PRICE SENSITIVE download Created with Sketch. 523.84KB
AC8 AC8 Appoints Experienced Global Pharma Executive as New CEO
25/02/19PRICE SENSITIVE download Created with Sketch. 124.01KB
AC8 AusCann Signs Cannabis Resin Supply Agreement with MediPharm
21/02/19PRICE SENSITIVE download Created with Sketch. 113.72KB
AC8 Appendix 3B - Release from Escrow
07/02/19 download Created with Sketch. 181.67KB
AC8 Appointment of Joint Company Secretary
01/02/19 download Created with Sketch. 96.86KB
AC8 December 2018 Quarterly Activities and Cashflow Report
31/01/19PRICE SENSITIVE download Created with Sketch. 1.09MB
AC8 AusCann Establishes Research and Development Facility
25/01/19PRICE SENSITIVE download Created with Sketch. 111.2KB
AC8 AusCann JV commences first cultivation activity with Khiron
22/01/19PRICE SENSITIVE download Created with Sketch. 101.44KB
AC8 Notification of Release of Securities from Escrow
17/01/19 download Created with Sketch. 101.96KB
AC8 Final Director's Interest Notice
02/01/19 download Created with Sketch. 81.96KB
AC8 AusCann Leadership Transition Update
17/12/18PRICE SENSITIVE download Created with Sketch. 103.27KB
AC8 Results of Annual General Meeting
27/11/18 download Created with Sketch. 147.53KB
AC8 Annual General Meeting Presentation
27/11/18 download Created with Sketch. 3.37MB
AC8 AC8 Moves First Products to Commercial Manufacturing Site
13/11/18PRICE SENSITIVE download Created with Sketch. 119.51KB
AC8 September 2018 Quarterly Activities and Cashflow Report
30/10/18PRICE SENSITIVE download Created with Sketch. 1.15MB
AC8 Annual Report
26/10/18 download Created with Sketch. 10.88MB
AC8 Notice of Annual General Meeting/Proxy Form
26/10/18 download Created with Sketch. 576.35KB
AC8 AusCann Releases Cannabinoid Medical Education Resources
02/10/18 download Created with Sketch. 327.28KB
AC8 AusCann Joint Venture Signs MoU with Khiron Life Sciences
01/10/18PRICE SENSITIVE download Created with Sketch. 114.25KB
AC8 Pharmaceutical Executive Joins AusCann Board & Appendix 3X
27/09/18 download Created with Sketch. 164.24KB
AC8 AusCann Announces Leadership Transition
27/09/18PRICE SENSITIVE download Created with Sketch. 109.38KB
AC8 Appendix 4G and 2018 Corporate Governance Statement
24/09/18 download Created with Sketch. 391.93KB
AC8 30 June 2018 Annual Financial Report
24/09/18 download Created with Sketch. 1.09MB
AC8 AusCann Commences Trading on US OTCQX Market
12/09/18 download Created with Sketch. 106.93KB
AC8 Progress Towards Production of Cannabinoid Medicines in FY18
31/08/18 download Created with Sketch. 141.11KB
AC8 Appendix 4E and Preliminary Final Report
31/08/18PRICE SENSITIVE download Created with Sketch. 398.66KB
AC8 Successful Pilot Study of Final Dose Cannabinoid Capsules
16/08/18PRICE SENSITIVE download Created with Sketch. 112.35KB
AC8 Change of Director's Interest Notice - B. McHarrie
13/08/18 download Created with Sketch. 108.85KB
AC8 Appendix 3B
09/08/18 download Created with Sketch. 165.85KB
AC8 AusCann Share Purchase Plan Raises $1.9m
09/08/18PRICE SENSITIVE download Created with Sketch. 109.97KB
AC8 June 2018 Quarterly Activities and Cashflow Report
31/07/18PRICE SENSITIVE download Created with Sketch. 471.63KB
AC8 Share Purchase Plan (SPP) Offer Document
19/07/18 download Created with Sketch. 335.98KB
AC8 Response to ASX Aware Query
19/07/18PRICE SENSITIVE download Created with Sketch. 742.64KB
AC8 AusCann Share Purchase Plan
16/07/18PRICE SENSITIVE download Created with Sketch. 140.61KB
(20min delay)
Last
15.0¢
Change
-0.010(6.25%)
Mkt cap ! $47.55M
Open High Low Value Volume
16.0¢ 16.0¢ 15.0¢ $287.0K 1.881M

Buyers (Bids)

No. Vol. Price($)
3 31178 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 125957 3
View Market Depth
Last trade - 16.10pm 18/09/2020 (20 minute delay) ?
(live)
Last
15.5¢
  Change
-0.010 ( 3.13 %)
Open High Low Volume
15.5¢ 16.0¢ 14.5¢ 677639
Last updated 15.58pm 18/09/2020 (live) ?
AC8 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.